Progress in the Diagnosis and Treatment of Rhabdomyosarcoma and Related Soft Tissue Sarcomas

@article{Ruymann2000ProgressIT,
  title={Progress in the Diagnosis and Treatment of Rhabdomyosarcoma and Related Soft Tissue Sarcomas},
  author={Frederick B. Ruymann and Alfred C. Grovas},
  journal={Cancer Investigation},
  year={2000},
  volume={18},
  pages={223 - 241}
}
Abstract Advances in the diagnosis and treatment of rhabdomyosarcoma and related soft tissue sarcomas continue in the Intergroup Rhabdomyosarcoma Study Group (1RSG) and European cooperative groups. The use of molecular biology techniques in soft tissue sarcomas are redefining the classic pathology of these small blue cell tumors. Improvements in imaging, radiotherapy, and surgery, in part, deserve credit for the better survival seen in all cooperative trials. These advances confound the… 
The development of VAC chemotherapy in Rhabdomyosarcoma: What does one do for an encore?
TLDR
This review documents the development of VAC and some of the new directions currently being pursued by the Children’s Oncology Group Soft Tissue Committee.
Clinical characteristics and the prognosis of childhood rhabdomyosarcoma in 60 patients treated at a single institute.
TLDR
Overall survival for rhabdomyosarcoma is dependent on histological subtype, primary site, disease group, duration of disease before treatment, and the type and time of recurrence.
RADICAL SURGERY AND IVA-CHEMOTHERAPEUTIC REGIMEN TO TREAT EMBRYONAL RHABDOMYOSARCOMA OF THE URACHUS: Case Report
TLDR
The authors describe another case in a 6-year-old female associated with constipation and a painless suprapubic mass and remains alive at 4 years’ follow-up with no signs of recurrence.
Advances in pediatric rhabdomyosarcoma characterization and disease model development.
TLDR
There has been a marked increase in the survival rate of RMS patients but the highly invasive, metastatic forms of the disease continue to baffle researchers.
Current chemotherapeutic strategies for rhabdomyosarcoma
TLDR
Current concepts on chemotherapy for rhabdomyosarcoma are covered, with an overview of the results of the main clinical trials conducted over recent years and considerations of possible strategies for the near future.
Adult laryngeal rhabdomyosarcoma: report of a case and literature review.
TLDR
A previously healthy non-smoker 77-year-old lady presented to the ENT outpatient with a six weeks history of intermittent alteration of voice quality, and Histology and immunohistochemistry examination suggested the diagnosis of mesenchymal neoplasm.
Rhabdomyosarcomas of the Nose and Paranasal Sinuses: Treatment Results in 15 Cases
Efficacy of ifosfamide and doxorubicin given as a phase II "window" in children with newly diagnosed metastatic rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study Group.
TLDR
It is concluded that ifosfamide/doxorubicin is highly active in advanced RMS, and should be considered for inclusion in frontline therapy for children with intermediate or high-risk RMS.
Feasibility of chemosensitivity testing in soft tissue sarcomas
TLDR
Chemosensitivity testing is feasible and can be used to create sensitivity and resistance profiles of established and new cytotoxic agents and their combinations in soft tissue sarcomas.
...
...

References

SHOWING 1-10 OF 114 REFERENCES
The role of combined chemotherapy in the treatment of rhabdomyosarcoma in children
TLDR
The results of this study support the adjunctive use of combined chemotherapy with actinomycin D and vincristine sulfate for 1 year in preventing growth of metastatic or recurrent disease when children are made grossly tumor free by surgery and radiotherapy.
Clinical features and results of therapy for children with paraspinal soft tissue sarcoma: a report of the Intergroup Rhabdomyosarcoma Study.
  • J. Ortega, M. Wharam, H. Maurer
  • Medicine
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 1991
TLDR
It is concluded that patients with paraspinal lesions may require extended-field radiation therapy to reduce the high local failure rate and more intensive chemotherapy to achieve better local and systemic tumor control.
Bladder/prostate rhabdomyosarcoma: results of the multi-institutional trials of the Intergroup Rhabdomyosarcoma Study.
  • D. Hays
  • Medicine
    Seminars in surgical oncology
  • 1993
TLDR
The most recent studies of the IRS and European cooperative groups suggest that a majority of RMS patients can survive with intact pelvic organs when treated with currently available chemotherapeutic agents in conjunction with radiotherapy and limited surgery.
Second malignant neoplasms in children treated for rhabdomyosarcoma. Intergroup Rhabdomyosarcoma Study Committee.
  • R. Heyn, V. Haeberlen, H. Maurer
  • Medicine
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 1993
TLDR
The results of this study suggest that genetic abnormalities play a prominent role in the development of an SMN after therapy for a primary RMS and Chemotherapy with an alkylating agent and radiotherapy play significant roles in theDevelopment of anSMN compared with patients who received only one of these therapeutic modalities.
Primary and metastatic rhabdomyosarcoma in the breast: neoplasms of adolescent females, a report from the Intergroup Rhabdomyosarcoma Study.
TLDR
Primary or metastatic RMS in breast is almost confined to adolescent females having tumors with alveolar histology, and approximately one-half of the patients with primary breast disease and 15% of those with metastatic breast disease as an initial recurrence are long-term survivors.
Rhabdomyosarcoma in children and adolescents. A review.
  • F. Ruymann
  • Medicine
    Hematology/oncology clinics of North America
  • 1987
Late effects of therapy in orbital rhabdomyosarcoma in children. A report from the intergroup rhabdomyosarcoma study
TLDR
The excellent survival in patients with orbital rhabdomyosarcoma provides support for treatment programs that use multiple‐agent chemotherapy and radiotherapy and do not include orbital exenteration initially.
Rhabdomyosarcoma in children.
TLDR
The most common site of tumor origin was in the head and neck region, but some arose in the extremities, urogenital system, and trunk, and the tumors grew rapidly, infiltrating locally and metastasizing to lung, bone, lymph nodes, and other organs.
Children with Vesical Rhabdomyosarcoma (RMS) Treated by Partial Cystectomy with Neoadjuvant or Adjuvant Chemotherapy, With or Without Radiotherapy A Report from the Intergroup Rhabdomyosarcoma Study (IRS) Committee
TLDR
Partial cystectomy is an alternative to total cyStectomy for bladder RMS when the tumor site makes it anatomically feasible and in patients with persistent areas of questionable residual tumor after otherwise apparently successful regimens of primary chemotherapy radiotherapy.
...
...